Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611620 · ClinicalTrials.gov registry record
Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 682
- Enrollment target
NCT04611620 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 682 participants.
The verdict
NCT04611620 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 682 participants
- Enrollment target
Study Summary
This descriptive, cross-sectional study will evaulate and fully characterize factors associated with cognitive dysfunction in Breast Cancer (BCS) and Colorectal Cancer (CRC) survivors that have cognitive concerns, and factors associated with psychoneurological symptom cluster in BCS and CRC survivors.
Interventions
- BEHAVIORAL Cognitive Dysfunction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 682 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04611620
The ClinicalTrials.gov registry entry for NCT04611620 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 682 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Dysfunction is the first listed.
NCT04611620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04611620 about?
NCT04611620 is a clinical study titled "Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms". This descriptive, cross-sectional study will evaulate and fully characterize factors associated with cognitive dysfunction in Breast Cancer (BCS) and Colorectal Cancer (CRC) survivors that have cognitive concerns, and factors associated with psychoneurological symptom cluster in BCS and CRC survivor...
What is the current status of trial NCT04611620?
This trial is currently completed. The enrollment target is 682 participants. The study started on 2020-11-16. Estimated completion is 2021-07-27.
What interventions are being tested in trial NCT04611620?
The interventions under investigation include: Cognitive Dysfunction (BEHAVIORAL).
Who is sponsoring clinical trial NCT04611620?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.